Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Bergmann

Showing results (181-190 of 254) with videos related to

Pageof 26
Sort By:
European Journal of Heart Failure|September 1, 2019
Circulating dipeptidyl peptidase 3 and alteration in haemodynamics in cardiogenic shock: results from the OptimaCC trialKoji Takagi, Alice Blet, Bruno Levy, et al.
Journal of the American College of Cardiology|October 22, 2013
Proenkephalin and prognosis after acute myocardial infarctionLeong L Ng, Jatinderpal K Sandhu, Hafid Narayan, et al.
Molecular Cell|November 26, 2008
Inactivation of effector caspases through nondegradative polyubiquitylationMark Ditzel, Meike Broemer, Tencho Tenev, et al.
Clinical Chemistry|January 30, 2010
Copeptin response to clinical maximal exercise testsMicha T Maeder, Daniel Staub, Martin H Brutsche, et al.
Minerva Endocrinologica|March 24, 2016
Modulation of circulating vasoactive peptides and extracellular matrix proteins are two novel mechanisms in the cardioprotective action of acarboseNatalia Rudovich, Olga Pivovarova, Wolfgang Bernigau, et al.
Journal of the American College of Cardiology|May 10, 2008
Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) studySohail Q Khan, Onkar Dhillon, Dominic Kelly, et al.
Diabetes Care|December 25, 2014
Effect of exogenous intravenous administrations of GLP-1 and/or GIP on circulating pro-atrial natriuretic peptide in subjects with different stages of glucose toleranceNatalia Rudovich, Olga Pivovarova, Özlem Gögebakan, et al.
Atherosclerosis|September 26, 2022
Growth hormone concentration and risk of all-cause and cardiovascular mortality: The REasons for Geographic And Racial Disparities in Stroke (REGARDS) studyNicholas Wettersten, Rohit Mital, Mary Cushman, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|November 4, 2015
Growth hormone for risk stratification and effects of therapy in acute myocardial infarctionLeong L Ng, Sanjay S Bhandari, Jatinderpal K Sandhu, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 8, 2011
Association of serum procalcitonin with cardiovascular prognosis in coronary artery diseaseChristoph R Sinning, Jan-Malte Sinning, Andreas Schulz, et al.
Pageof 26

Showing results (181-190 of 254) with videos related to

Sort By:
Pageof 26
European Journal of Heart Failure|September 1, 2019
Circulating dipeptidyl peptidase 3 and alteration in haemodynamics in cardiogenic shock: results from the OptimaCC trialKoji Takagi, Alice Blet, Bruno Levy, et al.
Journal of the American College of Cardiology|October 22, 2013
Proenkephalin and prognosis after acute myocardial infarctionLeong L Ng, Jatinderpal K Sandhu, Hafid Narayan, et al.
Molecular Cell|November 26, 2008
Inactivation of effector caspases through nondegradative polyubiquitylationMark Ditzel, Meike Broemer, Tencho Tenev, et al.
Clinical Chemistry|January 30, 2010
Copeptin response to clinical maximal exercise testsMicha T Maeder, Daniel Staub, Martin H Brutsche, et al.
Minerva Endocrinologica|March 24, 2016
Modulation of circulating vasoactive peptides and extracellular matrix proteins are two novel mechanisms in the cardioprotective action of acarboseNatalia Rudovich, Olga Pivovarova, Wolfgang Bernigau, et al.
Journal of the American College of Cardiology|May 10, 2008
Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) studySohail Q Khan, Onkar Dhillon, Dominic Kelly, et al.
Diabetes Care|December 25, 2014
Effect of exogenous intravenous administrations of GLP-1 and/or GIP on circulating pro-atrial natriuretic peptide in subjects with different stages of glucose toleranceNatalia Rudovich, Olga Pivovarova, Özlem Gögebakan, et al.
Atherosclerosis|September 26, 2022
Growth hormone concentration and risk of all-cause and cardiovascular mortality: The REasons for Geographic And Racial Disparities in Stroke (REGARDS) studyNicholas Wettersten, Rohit Mital, Mary Cushman, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|November 4, 2015
Growth hormone for risk stratification and effects of therapy in acute myocardial infarctionLeong L Ng, Sanjay S Bhandari, Jatinderpal K Sandhu, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 8, 2011
Association of serum procalcitonin with cardiovascular prognosis in coronary artery diseaseChristoph R Sinning, Jan-Malte Sinning, Andreas Schulz, et al.
Pageof 26